The goal of this investigation was to study the effects of sequential dust mite antigen stimulation on the appearanceandfunction ofthelarynx. To that end,wedesigned a randomized, placebo-controlled, double-blind, prospective analysis of adults who had tested positive for perennial dust mite allergy. The larynx ofpatients who received the active antigen waschallenged directly with a low (1:100) and a high (1:40) concentration of the dust mite allergen via an oral nebulizer. Voice laboratory assessment tools included voice and allergy questionnaires, videostroboscopic examination of the larynx, acoustic and speech aerodynamic analyses, and digitalaudiovoice recordings. The study was prematurely terminated after 2 patients had been treated with the highest concentration of the antigenic suspension because of adverse effects, including chest tightness, coughing, and voice difficulties. Both of these patients had.demonstrated viscous endolaryngeal secretions and vocal fold edema on videostroboscopy. No reactions were noted at the lower concentration of antigen exposure or in 1 control patient who completed the study. We believe that ourfindings, aspreliminaryas they are, may serve as an initial templatefor the differential diagnosis and treatment of otherpatients with inhalant allergies who presentwith chief complaints suggestive of allergic laryngitis.
Introduction
A great deal of debate has taken place over the past 40 years regarding the effects of allergy on the larynx. These discussions have centered on whether the laryngeal disturbances that have been noted in some allerg ic indivi dua ls represent (1) local en d-o rgan respo nses or (2) manifestations of systemic and multiple end -organ sequelae.1-3 Chadwick reported that the vast majority of studies oflaryngeal allergy have not demonstrated a true cause -and-effect relationship between antigen exposure and pathophysiologic lar yngeal reactions in patients with either seasonal or perennial allergies. ' In our previously published research, we challenged dust-mite-allergic patients wit h a fixed amount of an active an tigenic suspension via a n ebulizer.sWe then obtained measures of phonation and respiration subsystem responses to study potential disturbances in laryngeal biomechanics, acoustics, and speech aerodynamics that might accrue with such exposure. In that prospective investigation, we used a low concentration of antigen (1:200 weight/volume [w/v] ratio). Although we observed no statistically significant adverse effects, we did see a tendency toward higher-than-normal degrees of baseline and pos texposure endolar yngeal secretions in many of our patients. The fact that these results were consistent with findings reported by others prompted us to undertake the current investigation, the purpose of which was to increase the levels of dust mite antigen stimulation and obtain objective and subjective measurements of both laryngeal and pulmonary functional reactions in allergic patients. We hypothesized that antigenic suspensions administered at higher concentrations than those used in our previous study wou ld elicit a significant response in the larynx and that we wo uld be able to observe this response on acoustic analysis, speech aerodynamic testing, videostroboscopy, and audio voice recordings.
Patients and methods
Our investiga tion was designed as a ra ndomized, placebo-contro lled, do ub le-blind, prospective study. Consistent with our earlier investigation, we used a two-group pretest/post-test methodology in which patients were challenged with either the active antigen for Dermatophagoides ptetonyssinus or a placebo suspension . To control for bias or expectancy factors, the patients, examiners, and judges were blin ded to all experimental conditions.
Patients.Weobt ained appro val from the Human Investigation Committee at Wayne State University to recrui t 20otherwise health y,dust -mite-allergicpatients between the ages of 18 and 70 years from the patient popu lation at the university's Depa rt ment of Oto laryngology-Head and Neck Surgery in Detroit; patie nts were also recruited from University Otolaryngology,PC, a privatepractice outpatient clinic in Southfield, Mich . Because of the potential risks involved in directly stim ulating the bronchopulmonary tree and larynx with an allergen, we established extensive exclusion criteria. Evidence of anyone of the following factors excluded a patient from study participation: pregnancy (determined by a urine human chorionic gonadotropin [hCG] assessment before testing) , a history of smoking within the past 2 years, asthma, systemic corticosteroid treatment in the past 6 mo nths, imm unotherapy for allergy within the past 2 years, cur rent use of topica l or systemic antihistamines, current use of topical nasal or ora l inhalers, or a forced expiratory volume at 1second (FEV) ofless than 80% of predicted value.Allpotential risks ofantigen stimulation on the laryn x were explained , and informed consent was obtained from all patients prior to the study.
Allergy testing. The presence of allergy to D p teronyssinuswasassessed with a screening skin -pr ick test (Multi-Test II; Lincoln Diagnostics; Decatur, Ill.). Testing was done with 0.01 ml of a 1:20 w/v concentration of Der p l antigen placed into the superficial dermis. To qualify for participation, a patient had to exhibit a skin wheal respo nse of between 5 and 11 mm. These patie nts were then judged to be positive for the antigen without the need for further quantification ofthe degree ofreactivity. A positive histamine control was used to ensure normal skin reactivity, and a glycerin control was used to ensur e that patients were reacti ng to th e antigen and not to the glycerin preservative. 794 · www.entjournal.com A n tigen cha llenge . The active antigenic suspension was made by a technician by combining 1 ml of a 1:20 w/v Der p l antigen concentrate (Antigen Laboratories; Libert y, Mo.) in 9 ml of 0.4% phenolated normal saline, resulti ng in a 1:200 w/v suspension. The placebo was made by placing 1 ml of colored 50% glycerin in normal saline into 9 ml of 0.4% phe no lated normal saline. Colori zation was accomplished by inserting 3 drops of yellow food coloring into a 50-ml vial of 50% glycerin in saline. Th en two-fold and five-fold dilutions were ma de, resulting in suspensions of 1:100 and 1:40 w/v, respectively.All antigen and placebo suspe nsions were prepared within 1 week of use.
For laryngeal challenge, 0.5 ml of either th e Der p l antigenic suspension or the control suspension was administered via a DeVilbiss nebulizer (DeVilbiss Healthcare; Somerset, Pa.). All testing was conducted in the afternoon. Patients were instructed to breathe norma lly th rou gh their mo uths as the suspension was neb ulized. They inspired the material transorally over a period of5 minu tes, and they were observed throughout this period for any adverse reactions. If after 30 minutes any patient demonstrated no response to the inspired challenge and the FEV! remained greater than 80% of predicted, the entire testing batt ery was repeated with the highest concentration.
Laboratory testing battery. The stu dy was conducted in the Speech Physiolog y Laboratory at the Department of Otolaryngology-Head and Neck Surgery's outpatient clinical facility. The 7-step testing sequence for each patient was as follows:
1. Spirometry for FEV! 2. Completion of the VoiceHandicap Index (VHI) questionnaire 3. Completion of the Sinus Symptom Questionnaire" (SSQ) to ascertain allergy symp toms 4. Videostroboscopic examinat ion of the larynx 5. Analysesofacoustic characterist ics (fundamental frequency, harmonics/noise,jitter,and shimmer) and speech aerodynamic characteristics (m aximum phonation time, mean tra nsglottal airflow, glottal resistance, and subglottal air pressure) 6. Digital audio voice recordings 7. Antigen or placebo exposure via a neb ulizer Steps 1 through 6 were perfo rmed at baseline and 30 min utes after both an tigen challenges . In order to progress to challenge with the highest conce ntration of antige n, a patient had to register an FEV! of greater Exa mi ners and judges. The examiners-who were responsible for administering the skin-prick screen, test battery, and neb ulizer challenge-were blinded as to whether the patient was inh aling the antigen or the placebo. Following termination of th e study, two independent judges (a board-cert ified oto laryngologist and an American Speech-language-Hearing Associationcertified speech pathologist) ana lyzed the videostroboscopic and digital audio voice recordings. The judges were un aware of the identities of the patients on the recordings, and the y were also blinded as to whether the recordings had been made before or after exposure to the antigen or placebo. Videostroboscop ic find ings were rated for th e p resence, nature, and degree of supraglottic and glottic edema , erythema, and secretions; for the presence and size ofvocal fold polyps; and for the degree of vocal fold mobility and glottic competence (table 1). Digital audio recordings ofconnected discourse, picture descriptions, and prolonged vowel productions were rated by the judges for prosodic sufficiency, speech intelligibility, voice quality characteristics, and vocal pitch/loudness features on th e same 6-point scale (table 1). The judges
Results
In all, 3 pat ients (all men) completed all the challenges. We had plan ned to con duct this stu dy on 20 patie nts, but we were forced to terminatethe investigation prematurelyafter serious adverse pulmonary reactions were experienced by the first 2 patients who received the active antigen; in both of these patients, these reactions occurred following exposure to the highest antigen concentration. No reactions were noted at the lower concentration of an tigen exposure or in the 1 control patient who was exposed to the placebo.
With the exceptio n of th eir allergies, all 3 patients were in excellent health.Theydenied problems with acid reflux, and they had never smoked tobacco products .
Despite the premature termination ofthe study,we are still able to make some observations about the findings obtained for the 3 patients who underwent testing. Patient 1. This patient served as the control. Prior to exposure, he listed numerous complaints about his voice on the VHI; these complaints incl uded a varying qua lity of voice du ring th e day, vocal fatigue, and difficulty projecting voice in a loud environment. He also no ted a snoring problem on the SSQ. His VH I and SSQ responses revealed no change in status following the placebo challenges. The control patient's acoustic characteristics (figur e 1) and speech aerodynamic characteristics (figure 2) were all unremarkable prior to and following the placebo challenges ( figure 1) .
On videos tro boscop ic analysis, the judges did not perceive any substantial ana tomic or biomechanical abnormalities in th e larynx or vocal folds pr ior to or following each challenge ( figure 3, A; figure 4 , A and B). However, mild ly increased levels of supraglottic and glottic mucus accumulation were observed both at baseline and during challenge conditions. After listening to the audio voice recordi ngs, the judges perceived patient 1's voice abilities to be wit hin no rmal lim its at th e start of the study and thro ughout its duration. rated all their subjec tive findings on a scale of 1(normal) to 6 (severedi s turba~ce) (table  2) . Each judge was require d to evaluate each find ing on two sepa rate occasions in order to maximize intraand inter-judge reliability. Both intra-and inter-judge ratings had to be within 1 point of each other to be consi dered reliable. difficulties. His pulmonary capacity dropped markedly from well above 100% at th e first two measurements to 47%. Fortunately, this severe pulmonary reaction did not require treatment in the emergency room; it resol ved over the co urse of 30 minutes while the patient was carefully monitored by the examiners.
Findings on acoustic analysis (figure 1) remained within normal limits throughout the study, but speech aerodynamic analysis (figure 2) showed that patient 3's mean m aximum phonation time (figure 2,A) dec reased fro m more th an 20 seconds after the lower-concentration cha llenge to 8 seconds following the hi gh est-concentration cha llenge . The remaining measurements were individual reported mild voice complaints on the VHI and no complaints on the SSQ. His questionnaire responses rem ained unchanged following the lower-concentration challenge . However, after exposure to the highest concentration of antigen, h e di d experience ches t tigh tness, episodic cough ing, an d hoarseness.
His p ulmonary capacity as reflecte d in th e FEV1 measurement decl ined from more than 100% at baseline and after the Figure 1 . Charts show the acoustic findings in the control patient who received placebo (patient first challenge to 93% after 1) and the2 patients who received active antigen (patients 2 and 3). administration of the highest antigen concentration. Acoustic (figure 1) and speech aerodynamic (figur e 2) analyses did not reflect any notable differences across the entire experiment.
Anal ysis ofthe videostroboscopic recordings revealed that at base line, patient 2 had very mild vocal fold edema, erythema, and standing endolaryngeal secretions ( figure  3, B; figure 4 , C). Following exposure to the highest concentration of antigen, he exhibited evidence of mild supraglottic ede ma and erythema, mildly' increased levels of voca l fold edema and erythema, and more ab undant an d visco us en do laryngeal secre tions ( figure  3, B; figure 4, D ) . Patient 2's voice characteristics , whic h were norm al at baseli ne, were not perceived by the judges to have changed throughout the st udy ( figure  5, B) . within normal limits throughout the study. Videostroboscopy showed that patient 3 had very m ild supraglott ic and glottic edema, erythema, an d endo laryngea l secret ions at baseline (figure 3, C; figure 4, E). After administration of the lower concentration of antigen, he experienced a very slight increase in the degree of endolar yngeal secretions. But after exposure to the highest concentration, he experienced marked increases in vocal fold edema an d the degree and viscosity of en do laryngeal secretions ( figure 4, F) .
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Voice ana lysis revealed that after exposure to the highest concentration of antigen, patient 3 experienced a perceptible decrease in voice quality; at baseline, his speech and voice characteristics had been judged to be with in normal limits ( figure 5, C) .
Judges.Both int ra-and inter-judge reliability exceeded 90% for all of the videos tro boscopic and digital audio ratings.
Discussion
No study to our knowledge has concl usively shown that a cause-and-effect relationship exists between antigen expos ure an d direct changes in the ana tomy and function of the larynx. However, previous investigators have suggested that there is a high correlation between allergy and laryngeal signs and symptoms, including throat irritation, soreness, burn ing, and laryngitis.?:" These authors have also reported successfu l alleviation of these signs and symptoms with the administration of various empiric treatments, including allergen -specific immunotherapy.
The chief aim of the present study was to obtain objective and subjective evidence oflaryngeal pathophysiologi c reactio ns to dust mite exposure in individuals with known allergies to D pteronyssinus, a perennial antigen .We used a sequentially higher concentration of this stimulant for this study because our previous study failed to detect any such sequelae with low-concentration (1:200 w/v) exposure.' However, because of the onset of marked resp iratory distress and acute coughing following administra tion of th e high est conce ntra tion of antigen (1:40 w/v) , the study was terminated after only 3 patients had participated-2 who underwent active treatment and 1 placebo control.
Even so, the responses ofthe 2 patients who did receive the highest antigen concentration were particularly not eworthy. Patient 2 evidenced abo ut a 10% decrease in his FEV l level following such expos ure , and patient 3 experienced a reduction of about 50% along with severe wheezing and chest tightness symptoms. In both patients, mild coughing, hoarseness, and vocal fold edema and erythema occurred. Throat clear ing was observed in associa tion with abundant and viscous endolaryngeal standing secretions, which seemed to trigger th ese reactions and which were not present at baseline . What remains uncertain is whet her such mucus production orig inated in the larynx or was actually coughed upstream from the lower respiratory tract secondary to concomitant bro nchospasms.
It is important to int erpret the findings of this prewww.entjournal.com • 797 effects. While the se acute findin gs can be seen within mi nutes of significant antigen expo sure, it is likely th at a prolon ged exposure to antigen amo ng suscept ible individu als results in chronic laryngeal changes secondary to dysfunctional voice behaviors. It is probable that th ese chronic effects are respon sible for a significant po rt ion of the dysphonia obser ved in allergic patients with chronic laryngitis. Additional research is necessary to segregate the laryngeal finding s that are attributable to allergic stimulation liminaryinvestigation with cautio n, particularly in view of th e limited number of patien ts studie d. The data obt ained do not definitively demonstrate a cause-and-effect relation ship between allergen exposure and laryngeal pathology. However, the results do lend support to our experimentalhypothesis that adverse physiologic phonation and respiration subsystem reactions would be provoked in dust-mite-allergic patients if their larynges were deliberatelyexposed to high concentrations of D pteronyssinus. We suggest th at the laryngeal abnormalities noted in our patients occurred secondary to substantial lower respirato ry stimulation and irritative tracheobronchial responses.These combined reactions helped to illust rate both th e un ified functional relationship between th e anatomicallyinterconnected respiration and phonation subsystems and thei r co-occur ring vuln erabilit y to inhaled allergens.
Th e 2 patients in th e pre sent study who were exposed to the du st mit e antigen experienced a series of upp er and lower respiratory tract symptoms in a specific sequence immediately following th e administ ration of the highest an tigen concentration (table 3) . We believe th at th e proposed allergy model represented by this sequence helps to explain the specific findin gs in these 2 patients, and it may serve as an initialtemplate for the different ial diagnosis and treatment of ot her patient s with inha lant allergies who pr esent with chief complaint s suggestive of allergic laryngitis.
In conclusion, the role of allergy in chronic laryngeal inflammation and dysfunction isbecoming increasingly clear. Result s from the pr esent study demonstrate exposur e to increasing concentrations of antigen pro vokes both upp er and lower airway signs and symptoms. A combination of direct inflammatory changes in the endolarynx and secondary tr ansport of mucus to the larynx result s in coughin g, throat clearing, and oth er 79 fro m th e irritative and inflam ma tory effects th at are related to other kn own laryngeal path ologies. Of n ot e, laryn geal dysfunctio n related to laryngopharyn geal reflux and chronic voca l abuse must be evaluated in patients with allergic disease to determine if it plays an addit ive or synergistic role in the development of chronic laryngitis. We are currently in the process of implem enting prospective prot ocols in our labora-tory that are designed to address th e relative impact of th ese kn own patho logic pro cesses so th at we m ay m or e clearly defin e th e role of allergy in th e pathoge nesis of laryngeal dysfunction. Finally,stu dies aimed at m easuring the influences of ant igen stimulat ion on cyto log ic and histopathologic indicators would help refine our proposed model of laryngeal allergy.
